Celldex Therapeutics, Inc.
CLDXNasdaqCIK 744218HealthcareFiscal year ends Dec 31
Reports and events: 261 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2019-03-0716:11 ET | 10-K | Annual reportPeriod 2018-12-31 | 0001047469-19-000992 |
| 2019-03-0716:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-19-001578 |
| 2019-02-0811:49 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-19-006667 |
| 2018-12-1016:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-18-072097 |
| 2018-11-2709:18 ET | 8-K | 3.01 Delisting notice | 0001104659-18-070024 |
| 2018-11-0716:07 ET | 10-Q | Quarterly reportPeriod 2018-09-30 | 0001104659-18-066648 |
| 2018-11-0716:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-18-007706 |
| 2018-08-0816:06 ET | 10-Q | Quarterly reportPeriod 2018-06-30 | 0001104659-18-050496 |
| 2018-08-0816:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-18-005867 |
| 2018-06-1416:01 ET | 8-K | 5.07 Shareholder vote results | 0001104659-18-040165 |
| 2018-06-0108:00 ET | 8-K | 3.01 Delisting notice | 0001104659-18-037447 |
| 2018-05-1008:19 ET | 10-Q | Quarterly reportPeriod 2018-03-31 | 0001104659-18-031972 |
| 2018-05-1008:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-18-003787 |
| 2018-04-3009:00 ET | DEF 14A | Proxy statementPeriod 2018-06-13 | 0001047469-18-003326 |
| 2018-04-2416:01 ET | 8-K | 2.05 Exit or disposal costs | 0001104659-18-026170 |
| 2018-04-1607:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-18-002723 |
| 2018-03-0716:11 ET | 10-K | Annual reportPeriod 2017-12-31 | 0001047469-18-001363 |
| 2018-03-0716:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-18-001754 |
| 2017-12-2907:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-17-075519 |
| 2017-11-0916:26 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-17-067404 |
| 2017-11-0708:22 ET | 10-Q | Quarterly reportPeriod 2017-09-30 | 0001104659-17-066472 |
| 2017-11-0708:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-17-006680 |
| 2017-10-0308:09 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-17-060390 |
| 2017-09-1216:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-17-056738 |
| 2017-08-0816:06 ET | 10-Q | Quarterly reportPeriod 2017-06-30 | 0001104659-17-050250 |
| 2017-08-0816:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-17-004841 |
| 2017-07-0516:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-17-043557 |
| 2017-06-1608:58 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-17-039747 |
| 2017-05-0916:06 ET | 10-Q | Quarterly reportPeriod 2017-03-31 | 0001104659-17-031139 |
| 2017-05-0916:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-17-002857 |
| 2017-04-2816:11 ET | DEF 14A | Proxy statementPeriod 2017-06-15 | 0001047469-17-003056 |
| 2017-03-1416:23 ET | 10-K | Annual reportPeriod 2016-12-31 | 0001047469-17-001564 |
| 2017-03-1416:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-17-001503 |
| 2017-03-0116:03 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-17-013035 |
| 2017-02-0716:02 ET | 8-K/A | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001104659-17-006973 |
| 2016-12-1416:07 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-16-162070 |
| 2016-12-0516:03 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-16-160632 |
| 2016-11-2916:04 ET | 8-K | 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-16-159586 |
| 2016-11-0716:16 ET | 10-Q | Quarterly reportPeriod 2016-09-30 | 0001104659-16-155185 |
| 2016-11-0716:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-16-013004 |
| 2016-11-0116:07 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-16-153723 |
| 2016-08-1108:02 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-16-138856 |
| 2016-08-0816:11 ET | 10-Q | Quarterly reportPeriod 2016-06-30 | 0001104659-16-137913 |
| 2016-08-0816:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-16-011578 |
| 2016-06-0910:37 ET | 8-K | 5.07 Shareholder vote results | 0001104659-16-126316 |
| 2016-05-1916:04 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-16-122085 |
| 2016-05-0508:43 ET | 10-Q | Quarterly reportPeriod 2016-03-31 | 0001104659-16-118017 |
| 2016-05-0508:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-16-009727 |
| 2016-04-2108:03 ET | DEF 14A | Proxy statementPeriod 2016-06-08 | 0001047469-16-012401 |
| 2016-03-0707:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-16-008396 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 5, 2026, 19:04 ET. Listed shows no prices and gives no investment advice.